Furthermore, in BM tumors, the increased secretion of CCL2 recruits Iba1+ myeloid cells, which reciprocally enhance BM tumor cell outgrowth via enhanced proliferation and reduced apoptosis (35, 36). The gene discussed is CCL2; the disease is neoplasm.